Basic Molipaxin Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In United Kingdom: Trazodone (often sold by its INN); tablets commonly available in 50 mg, 100 mg, 150 mg and 300 mg strengths; capsules and oral liquid preparations are also marketed.
• ATC Code: N06AX05
• Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; oral solution commonly around 10 mg/mL (varies by market); capsules 50 mg and 100 mg in some supplies.
• Manufacturers In United Kingdom: Original developer Pfizer (US); European suppliers include Angelini Pharma for prolonged‑release formulations and multiple generic manufacturers such as Teva, Sandoz, Mylan, Torrent, Sun Pharma and KRKA supply trazodone products.
• Registration Status In United Kingdom: Prescription‑only medicine; marketed in the UK generally under the INN trazodone with approvals consistent with European licensing (national variations apply).
• OTC / Rx Classification: Prescription‑only; not available over the counter.

Read this as practical, patient‑centred information about molipaxin — the active substance is trazodone as shown above.

Always follow a UK prescriber’s instructions from your GP, psychiatrist or hospital clinic and check MHRA or NHS patient leaflets for the product you receive.

Do not stop or change your dose suddenly; tapering is usually recommended to avoid withdrawal symptoms.

Avoid alcohol while taking molipaxin and be cautious with over‑the‑counter sleep remedies or sedating antihistamines.

If you drive or operate machinery, delay these activities until you know how molipaxin affects you because sedation and orthostatic dizziness are common side effects.

If you are taking MAO inhibitors, have had a recent myocardial infarction, known cardiac disease, liver or kidney problems, or a history of seizures, discuss alternatives with your prescriber as these are recognised cautions or contraindications.

Report side effects to your GP, pharmacist or via the MHRA Yellow Card scheme.

For prescription supply, NHS routes such as repeat prescriptions, NHS 111 and your local GP surgery are preferred; major chains including Boots, LloydsPharmacy and Superdrug, and registered online pharmacies can dispense on a valid prescription.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Many patients ask whether molipaxin should be taken in the morning or at night.

For insomnia or when sedation is desired, a single evening dose at bedtime is common, typically 25–100 mg for off‑label sleep use.

For antidepressant therapy the usual regimen is divided daytime doses with a starting total around 150 mg per day, titrated by the prescriber to effect.

If daytime drowsiness occurs, speak to your GP about shifting the larger dose to the evening or lowering the dose to improve daytime alertness.

Elderly patients frequently start at lower doses and often take their dose at night to reduce the risk of daytime falls caused by orthostatic hypotension.

Taking With Or Without Meals (UK Diet Habits)

UK diets vary from light breakfasts to heavier evening meals, and food can influence tolerability.

Taking molipaxin with a light snack often reduces nausea without markedly affecting overall benefit.

A heavy, high‑fat meal may alter the absorption of some formulations, so follow the label or pharmacy advice for your particular product.

Keep a simple daily pill checklist or a dosette box to avoid missed doses.

• Tip: Mark days on a calendar or use a weekly dosette box to plan doses.
• Tip: Use alarm reminders on a phone for divided antidepressant doses.
• Tip: Note any daytime drowsiness in a diary for the prescriber to review.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Molipaxin must not be used by anyone with known hypersensitivity to trazodone.

Do not take it concurrently with MAO inhibitors or within 14 days of starting or stopping an MAOI because of serious interaction risk.

Avoid use in the acute recovery phase following myocardial infarction unless carefully reviewed by cardiology and psychiatry teams.

Use caution for patients with unstable cardiac disease, arrhythmia risk, severe hepatic or renal impairment and a history of seizures.

Children are not approved for trazodone use and it should generally be avoided in paediatric patients.

Activities To Limit (Driving, Work Safety)

Avoid driving, cycling and operating heavy machinery until you know how molipaxin affects you.

Sedation, dizziness and blurred vision are listed side effects that can impair road safety.

If work involves safety‑critical tasks, inform occupational health or your employer and seek medical advice about fitness to work.

Pregnant or breastfeeding women should discuss risks and benefits with their prescriber before starting treatment.

• Checklist For Contraindications: Hypersensitivity; recent MAOI use; recent MI; unstable cardiac disease; severe hepatic/renal impairment; seizure history.
• Activity Restrictions Summary: Driving/operation of machinery — avoid until stable; Alcohol — avoid; Safety‑critical roles — inform occupational health.

Dosage & Adjustments

General Regimen (NHS Guidance)

For major depressive disorder the typical adult starting dose is about 150 mg per day given in divided doses, adjusted by the prescriber according to response and tolerability.

Outpatient maxima are commonly around 400 mg per day, with higher inpatient limits up to 600 mg in hospital settings under specialist care.

For insomnia, clinicians often use low single bedtime doses off‑label, usually 25–100 mg and in most cases not exceeding 150 mg for sleep.

Do not double a missed dose; take the missed dose when remembered unless it is almost time for the next dose.

Special Cases (Elderly, Comorbidities)

Elderly and frail patients should start low and go slow because of increased risk of sedation and orthostatic hypotension.

Many clinicians begin at one‑third or one‑half of the usual adult starting dose and titrate cautiously.

For hepatic or severe renal impairment dose reduction and closer clinical monitoring are recommended, with adjustments made according to lab results and clinical judgement.

Children: trazodone is not approved for paediatric use and should be avoided.

• Missed Dose Advice: Take as soon as remembered unless the next dose is near; do not double up.
• Titration Checklist For Clinicians: Start low; monitor blood pressure and sedation; review interactions; reassess at 1–2 weeks and again at 4–6 weeks.

User Testimonials

Positive Reports From UK Patients

Many UK patients report improved sleep continuity when taking low‑dose molipaxin at night.

Patients who had early morning awakening describe sleeping for longer stretches after starting trazodone at bedtime.

Some people with depression notice mood benefits after several weeks when trazodone is used as part of an antidepressant regimen.

Reports frequently mention that sexual side effects are less problematic than with some SSRIs, though experiences vary.

Common Challenges (Patient.info, NHS Forums)

Commonly reported downsides are daytime drowsiness, dry mouth, dizziness when standing and occasional headaches.

Patient forums such as Patient.info and NHS community pages often advise gradual dose adjustment to reduce sedation.

Some patients say it takes several weeks to see mood improvements, while sleep benefits can occur sooner.

• Pros: Better night‑time sleep, reduced early waking, sometimes improved mood.
• Cons: Daytime sleepiness, dry mouth, dizziness on standing, occasional constipation.
• When To Contact GP: Worsening mood, new or worsening suicidal thoughts, fainting, chest pain or severe side effects.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Molipaxin is prescription‑only in the UK and must be supplied on a valid prescription.

Prescription supply routes include your GP, mental health team or hospital clinic and community pharmacies such as Boots, LloydsPharmacy and Superdrug dispense on presentation of a valid prescription.

Registered online pharmacies in the UK are able to dispense on receipt of a prescription; check they are registered with the General Pharmaceutical Council and provide a UK contact address.

In our online pharmacy, molipaxin is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Price Comparison (NHS Prescription Charge Vs Private)

Under the NHS a standard prescription charge applies in England unless the patient is exempt, and prescriptions are free in Scotland, Wales and Northern Ireland.

Private prescription costs vary according to the prescriber, the pharmacy and whether a branded or generic preparation is supplied.

Branded or prolonged‑release formulations tend to cost more than generic tablets.

• Safe Online Pharmacy Checklist: Check GPhC registration, read the patient information leaflet supplied, confirm a UK address and a pharmacist contact number.
• Price Tip: Ask the dispensing pharmacy for a generic option if cost is a concern and it is clinically acceptable.

What’s Inside & How It Works

Ingredients Overview

The active ingredient in molipaxin is trazodone hydrochloride as listed above.

Formulations in the UK include tablets (50 mg, 100 mg, 150 mg, 300 mg), capsules and oral liquids, with packaging in blisters or bottles depending on the manufacturer.

Excipients vary between manufacturers, so patients with allergies should check the specific product leaflet supplied with their medicine.

• Allergy Check: Read the patient information leaflet for excipient detail before taking a new pack.

Mechanism Basics Explained Simply

Trazodone modulates serotonin signalling and has some serotonin reuptake inhibition as part of its action profile.

Its sedative effects are in part due to antagonism at histamine H1 receptors and alpha‑adrenergic blocking activity, which also account for blood pressure changes such as orthostatic hypotension.

Think of molipaxin as an antidepressant with prominent sedative properties that can be useful when insomnia coexists with depression.

Main Indications

Approved Uses (MHRA Listing)

The primary approved indication for trazodone is major depressive disorder in adults.

Some prolonged‑release formulations are used in Europe for sleep‑related symptoms within depressive illness, subject to national approvals.

Trazodone is prescription‑only and prescribing should align with MHRA guidance and local NHS formularies.

Off‑Label Uses In UK Clinics

UK clinicians commonly prescribe low doses of trazodone off‑label for insomnia, especially when depression or anxiety coexist.

Typical sleep dosing for off‑label use is 25–100 mg at night and most prescribers do not exceed 150 mg for sleep purposes.

Use in children is not approved and elderly patients require lower starting doses and closer monitoring.

• Approved Vs Off‑Label: Approved — major depressive disorder. Off‑label — low‑dose sleep treatment when clinically indicated.
• Referral Flow: If sleep problems persist, consider referral to GP or mental health services for assessment and therapy options.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Do not drink alcohol while taking molipaxin as it increases sedation and the risk of impaired coordination.

Caffeine from tea or coffee does not have a major direct pharmacological interaction with trazodone, but it can worsen insomnia if taken late in the day.

Avoid combining molipaxin with other sedatives without medical advice because of additive depressant effects.

Drug Conflicts (MHRA Yellow Card Reports)

Do not combine molipaxin with MAO inhibitors or use it within 14 days of stopping an MAOI due to the risk of severe interactions.

Caution is required when combining trazodone with other serotonergic drugs because of a potential risk of serotonin syndrome.

CYP3A4 inhibitors can raise trazodone blood levels and may require dose adjustment or enhanced monitoring.

Cardiac medicines and certain antiarrhythmics should be reviewed by the prescriber because of rare arrhythmia risk associated with trazodone.

• Show These To Your Pharmacist: MAOI use, other antidepressants, strong CYP3A4 inhibitors, heart medicines, seizure history.
• Report Suspected ADRs: Use the MHRA Yellow Card scheme to report adverse drug reactions.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent literature between 2022 and 2025 emphasises trazodone’s role for improving sleep continuity when insomnia is associated with depression.

Trials and observational studies in elderly populations highlight tolerability issues such as orthostatic hypotension and daytime sedation and recommend cautious dosing.

Meta‑analyses suggest trazodone is a viable alternative when SSRIs are ineffective or not tolerated, but head‑to‑head results differ depending on outcomes selected.

Regulatory updates have drawn attention to rare cardiac effects and reinforce the importance of reporting via Yellow Card for pharmacovigilance.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

When molipaxin is unsuitable, NHS prescribers may consider SSRIs such as sertraline or paroxetine for primary depression.

Mirtazapine is an alternative with sedative antidepressant properties and a different sexual side‑effect profile.

Amitriptyline can be effective for severe insomnia with depression but carries a higher anticholinergic burden and is less suitable for some elderly patients.

• Pros/Cons Checklist: Efficacy for mood, sedative effect, side‑effect profile, interaction risk, suitability in elderly.

When To Discuss Switching

Discuss changing treatment if side effects such as persistent sedation or hypotension impair daily life.

If there is no meaningful benefit after 4–6 weeks at an optimised dose, speak to the prescriber about alternatives.

Switching should also be considered when dangerous drug–drug interactions are identified or when pregnancy planning alters risk profiles.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Trazodone is prescription‑only and regulated in the UK under MHRA oversight with prescribing guided by the BNF and local formularies.

NHS prescribing follows clinician judgement and local trust policies, with monitoring as required for cardiac or hepatic risk factors.

International Notes (ANMDMR, EMA, FDA)

Internationally trazodone is approved under various brand names including Desyrel in the United States and Trittico in parts of Europe.

Registration details can be searched via EMA, the FDA database and national agencies such as Romania’s ANMDMR where it appears as Trazodonă.

The ATC classification is N06AX05, categorising it among other antidepressants.

FAQ Section

Will Molipaxin Make Me Sleepy All Day?

Molipaxin commonly causes drowsiness, especially when treatment starts or after dose increases.

Many patients tolerate night dosing well but daytime sleepiness can occur and should be discussed with your GP for dose timing adjustments.

Is It Safe With My Heart Tablets?

Tell your clinician about all heart medications you take because trazodone can affect blood pressure and cardiac rhythm, and checks may be needed.

Can I Drink Alcohol?

No, alcohol increases sedation and coordination impairment when combined with molipaxin and should be avoided.

How Long Until It Works For Depression?

Sleep benefits are sometimes noticed quickly, but mood improvement usually takes 4–6 weeks at therapeutic antidepressant doses.

• When To Call GP: Worsening mood, new suicidal thoughts, fainting, chest pain, or severe allergic reactions.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Confirm the indication, exact dose and timing when dispensing molipaxin to a patient.

Warn about sedation, orthostatic hypotension and the need to avoid alcohol and other sedatives unless advised otherwise.

Review the patient’s current medicines for MAOIs, other serotonergic drugs and CYP3A4 inhibitors and check for allergies to excipients.

Advise on storage at room temperature (15°C–30°C) and to keep the medicine out of reach of children.

• Simple Patient Checklist: Take as prescribed; avoid alcohol; do not drive until stable; report side effects to GP or via Yellow Card.

NHS Patient Support Advice

Use GP follow‑ups, mental health services and IAPT‑type psychological therapies where available as part of a combined care plan.

Community pharmacy can support with medication reviews and help identify adherence or side‑effect issues.

Provide emergency instructions for severe signs such as severe drowsiness, fainting, irregular heartbeat or suicidal thoughts, which require immediate medical attention.

Delivery Across United Kingdom